2.267 LONG-TERM EFFICACY OF SAFINAMIDE AS ADD-ON TO LEVODOPA IN PARKINSON'S DISEASE (PD) USING AN ‘ON’ AND ‘ON-OFF’ TREATMENT ANALYSIS von Anand, R, Borgohain, R, Bhatt, M, Stocchi, F, Chirileanu, D, Lucini, V

Volltext

Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations von Borgohain, Rupam, Szasz, J., Stanzione, P., Meshram, C., Bhatt, M., Chirilineau, D., Stocchi, F., Lucini, V., Giuliani, R., Forrest, E., Rice, P., Anand, R.

Volltext

Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease von Borgohain, Rupam, Szasz, Jozsef, Stanzione, Paolo, Meshram, Chandrashekhar, Bhatt, Mohit H., Chirilineau, Dana, Stocchi, Fabrizio, Lucini, Valentina, Giuliani, Rodolfo, Forrest, Emma, Rice, Patricia, Anand, Ravi

Volltext

MRI findings in toxoplasmosis cerebralis von Rosca, Elena Cecilia, Rosca, Ovidiu, Simu, Mihaela, Chirileanu, Ruxandra Dana

Volltext

Neurocognitive disorders due to HIV infection von Rosca, E.C, Rosca, O, Chirileanu, R.D, Simu, M

Volltext

Cognitive impairment aspects in subcortical dementia patients von Chirileanu, R.D, Simu, M, Reisz, D, Popa, R, Tamasan, S

Volltext